3D Signatures (DXD) Stock Price, News & Analysis

Company Overview

3D Signatures Inc., a personalized medicine company, focuses on the development and commercialization of predictive technological products. Its proprietary software platform predicts the course of certain diseases and personalizes the treatment for individual patients. The company's TeloView software platform measures the stage of the disease, rate of progression of the disease, how different diseases will respond to various therapies, and drug efficacy and toxicity. It is developing five diagnostic and prognostic products for cancers and neurological disorders, including Hodgkin's lymphoma, prostate cancer, multiple myeloma, lung cancer, and Alzheimer's diseases. The company is headquartered in Toronto, Canada.

Key Stats

• Today's Range: C$0.04 to C$0.04
• 50-Day Range: C$0.04 to C$0.04
• 52-Week Range: C$0.03 to C$0.25
• Volume: 5,000 shs
• Average Volume: 30,759 shs
• Market Capitalization: C$2.66 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: CVE
• Sector: Healthcare
• Industry: Life Sciences Tools & Services
• Sub-Industry: Life Sciences Tools & Services
• Current Symbol: CVE:DXD
• CIK: N/A
• Web: www.3dsignatures.com
• Phone: +1-204-5820922
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.08
• Quick Ratio: 0.05

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: C$0.00 per share
• Price / Cash Flow: 22.50
• Book Value: C($0.01) per share
• Price / Book: -3.64

Miscellaneous

• Outstanding Shares: 66,532,000
• Free Float: N/A
• Market Cap: C$2.66 million
• Optionable: Not Optionable
• Beta: N/A